Pfizer

PFE · NYSE · USD

$27.63−1.76%−$0.50

Close · October 2, 2026

At a glance

Revenue growth
−1.65%
2025 vs 2024
Net income growth
−3.24%
2025 vs 2024
Net margin
12.4%
2024: 12.6%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets201,131207,618208,160208,731206,095208,028213,396219,476216,193221,095226,501215,021
Current assets41,35842,82242,89846,92443,70345,86150,35843,22337,82542,41543,33374,012
Cash and equivalents9761,7031,1421,3431,6381,4301,0431,0921,0527192,8533,148
Short-term investments10,72311,37212,45413,64111,61115,88719,4348,8606,04811,2099,83741,033
Receivables16,19216,17315,84118,11516,09414,74514,77717,69415,08715,22215,54415,003
Inventory9,94510,66710,65411,46811,66910,85210,85111,72111,44710,89210,18910,204
Net property, plant and equipment19,02919,40221,53018,88018,77618,34720,68218,54118,95718,80321,86417,862
Goodwill71,41971,40971,26469,10168,99768,44468,52768,57068,44569,29767,78351,527
Other intangible assets47,05352,55953,73151,32452,70253,97655,41159,98661,24062,82964,90040,224
Long-term investments1,4601,5061,5272,0562,0481,9172,10810,82711,04811,52415,38214,113
Current liabilities32,64634,34836,98436,59637,72636,45242,99543,21143,81940,49747,79431,136
Accounts payable4,5814,5065,2405,0245,1665,2405,6335,3145,1065,5916,7105,338
Long-term debt60,77260,84061,85657,62557,73157,91757,80258,21857,88161,65361,81361,581
Total debt63,38664,70267,49061,88261,99561,67664,22261,99261,65962,671——
Total liabilities115,639117,214121,385115,635117,083117,391124,899126,918128,218128,537137,213117,817
Total equity (incl. minority)85,49290,40486,77593,09689,01290,63788,49792,55887,97592,55889,28897,204
Retained earnings112,087117,238114,610121,150117,609119,590116,725121,059116,596121,318118,353126,411
Minority interest302303299295317299294272275276274270